1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
727,785
$56.0m40.76%
40.76%
Reduced Shares held: Q3 2021 796.1k, Q4 2021 766.1k, Q1 2022 754.1k, Q2 2022 727.8k
-26.3k
-26,321
-3.5%
2
ELUTIA INC
CL A COM
ELUT
ELUT
1,418,123
$10.0m7.29%
7.29%
Added Shares held: Q3 2021 50.0k, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
+200
+200
0.0%
3
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
85,240
$8.3m6.04%
6.04%
Reduced Shares held: Q3 2021 80.2k, Q4 2021 89.2k, Q1 2022 89.2k, Q2 2022 85.2k
-4.0k
-4,000
-4.5%
4
QUIDEL CORP
COM
QDEL
QDEL
61,306
$6.0m4.33%
4.33%
Added Shares held: Q3 2021 59.7k, Q4 2021 59.7k, Q1 2022 59.7k, Q2 2022 61.3k
+1.6k
+1,622
2.7%
5
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
284,843
$3.9m2.82%
2.82%
Reduced Shares held: Q3 2021 314.1k, Q4 2021 314.1k, Q1 2022 294.1k, Q2 2022 284.8k
-9.3k
-9,300
-3.2%
6
OVINTIV INC
COM
OVV
OVV
84,200
$3.7m2.71%
2.71%
Added Shares held: Q3 2021 34.2k, Q4 2021 34.2k, Q1 2022 34.2k, Q2 2022 84.2k
+50.0k
+50,000
146.2%
7
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
15,000
$3.5m2.57%
2.57%
Reduced Shares held: Q3 2021 18.0k, Q4 2021 18.0k, Q1 2022 18.0k, Q2 2022 15.0k
-3.0k
-3,000
-16.7%
8
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
249,400
$3.5m2.56%
2.56%
Added Shares held: Q3 2021 199.4k, Q4 2021 199.4k, Q1 2022 199.4k, Q2 2022 249.4k
+50.0k
+50,000
25.1%
9
BIODESIX INC
COM
COM
1,811,412
$2.9m2.13%
2.13%
Added Shares held: Q3 2021 1.1m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.8m
+558.7k
+558,659
44.6%
10
PROTHENA CORP PLC
SHS
PRTA
PRTA
102,548
$2.8m2.03%
2.03%
Added Shares held: Q3 2021 40.2k, Q4 2021 40.2k, Q1 2022 42.0k, Q2 2022 102.5k
+60.6k
+60,570
144.3%
11
CONTINENTAL RES INC
COM
CLR
CLR
38,600
$2.5m1.84%
1.84%
Unchanged Shares held: Q3 2021 38.6k, Q4 2021 38.6k, Q1 2022 38.6k, Q2 2022 38.6k
12
ALBIREO PHARMA INC
COM
BIOD
BIOD
113,000
$2.2m1.63%
1.63%
Unchanged Shares held: Q3 2021 113.0k, Q4 2021 113.0k, Q1 2022 113.0k, Q2 2022 113.0k
13
ACCELERATE DIAGNOSTICS INC
COM
COM
2,252,388
$2.2m1.63%
1.63%
Unchanged Shares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
14
BIOHAVEN PHARMACTL HLDG CO L
COM
BHVN
BHVN
15,000
$2.2m1.59%
1.59%
Added Shares held: Q3 2021 10.0k, Q4 2021 12.0k, Q1 2022 14.0k, Q2 2022 15.0k
+1.0k
+1,000
7.1%
15
PHREESIA INC
COM
PHR
PHR
82,700
$2.1m1.50%
1.50%
Added Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 10.0k, Q2 2022 82.7k
+72.7k
+72,700
727.0%
16
MASIMO CORP
COM
MASI
MASI
15,280
$2.0m1.45%
1.45%
Added Shares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 9.3k, Q2 2022 15.3k
+6.0k
+6,000
64.7%
17
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$1.5m1.08%
1.08%
Unchanged Shares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
18
GOSSAMER BIO INC
COM
GOSS
GOSS
159,088
$1.3m0.97%
0.97%
Added Shares held: Q3 2021 40.0k, Q4 2021 100.0k, Q1 2022 129.1k, Q2 2022 159.1k
+30.0k
+30,000
23.2%
19
HARROW INC
COM
HROW
HROW
180,000
$1.3m0.95%
0.95%
Unchanged Shares held: Q3 2021 180.0k, Q4 2021 180.0k, Q1 2022 180.0k, Q2 2022 180.0k
20
KARYOPHARM THERAPEUTICS INC
COM
COM
269,332
$1.2m0.88%
0.88%
Unchanged Shares held: Q3 2021 246.0k, Q4 2021 246.0k, Q1 2022 269.3k, Q2 2022 269.3k
21
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
50,000
$1.2m0.86%
0.86%
Unchanged Shares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
22
CYTOKINETICS INC
COM NEW
CYTK
CYTK
25,000
$982.0k0.71%
0.71%
Unchanged Shares held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 25.0k
23
AVEO PHARMACEUTICALS INC
COM NEW
AVEO
AVEO
140,000
$918.0k0.67%
0.67%
Unchanged Shares held: Q3 2021 40.0k, Q4 2021 140.0k, Q1 2022 140.0k, Q2 2022 140.0k
24
PIONEER NAT RES CO
COM
PXD
PXD
3,800
$848.0k0.62%
0.62%
Unchanged Shares held: Q3 2021 3.8k, Q4 2021 3.8k, Q1 2022 3.8k, Q2 2022 3.8k
25
EQUITRANS MIDSTREAM CORP
COM
ETRN
ETRN
133,050
$846.0k0.62%
0.62%
Unchanged Shares held: Q3 2021 133.1k, Q4 2021 133.1k, Q1 2022 133.1k, Q2 2022 133.1k
26
INHIBRX INC
COM
INBX
INBX
70,448
$800.0k0.58%
0.58%
Added Shares held: Q3 2021 0, Q4 2021 40.0k, Q1 2022 50.4k, Q2 2022 70.4k
+20.0k
+20,000
39.6%
27
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
59,833
$790.0k0.57%
0.57%
Added Shares held: Q3 2021 0, Q4 2021 28.0k, Q1 2022 34.3k, Q2 2022 59.8k
+25.5k
+25,500
74.3%
28
DOCGO INC
COM
DCGO
DCGO
110,000
$785.0k0.57%
0.57%
Unchanged Shares held: Q3 2021 0, Q4 2021 10.0k, Q1 2022 110.0k, Q2 2022 110.0k
29
INARI MED INC
COM
NARI
NARI
10,000
$680.0k0.49%
0.49%
Added Shares held: Q3 2021 7.0k, Q4 2021 7.0k, Q1 2022 8.0k, Q2 2022 10.0k
+2.0k
+2,000
25.0%
30
SOLENO THERAPEUTICS INC
COM
COM
3,676,899
$680.0k0.49%
0.49%
Unchanged Shares held: Q3 2021 876.9k, Q4 2021 876.9k, Q1 2022 3.7m, Q2 2022 3.7m
31
IMMUNOGEN INC
COM
IMGN
IMGN
150,000
$675.0k0.49%
0.49%
Reduced Shares held: Q3 2021 190.0k, Q4 2021 190.0k, Q1 2022 190.0k, Q2 2022 150.0k
-40.0k
-40,000
-21.1%
32
ARVINAS INC
COM
ARVN
ARVN
15,000
$631.0k0.46%
0.46%
Unchanged Shares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
33
CONTRAFECT CORP
COM
CFRX
CFRX
200,000
$614.0k0.45%
0.45%
Unchanged Shares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
34
TURNING POINT THERAPEUTICS I
COM
COM
8,000
$602.0k0.44%
0.44%
Unchanged Shares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k, Q2 2022 8.0k
35
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
45,114
$578.0k0.42%
0.42%
Unchanged Shares held: Q3 2021 45.1k, Q4 2021 45.1k, Q1 2022 45.1k, Q2 2022 45.1k
36
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
12,000
$543.0k0.39%
0.39%
Unchanged Shares held: Q3 2021 12.0k, Q4 2021 12.0k, Q1 2022 12.0k, Q2 2022 12.0k
37
CHEMOCENTRYX INC
COM
CCXI
CCXI
20,000
$496.0k0.36%
0.36%
Unchanged Shares held: Q3 2021 25.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
38
NEKTAR THERAPEUTICS
COM
COM
128,000
$486.0k0.35%
0.35%
Unchanged Shares held: Q3 2021 72.0k, Q4 2021 100.0k, Q1 2022 128.0k, Q2 2022 128.0k
39
IRHYTHM TECHNOLOGIES INC
COM
IRTC
IRTC
4,000
$432.0k0.31%
0.31%
Unchanged Shares held: Q3 2021 4.0k, Q4 2021 4.0k, Q1 2022 4.0k, Q2 2022 4.0k
40
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
38,000
$408.0k0.30%
0.30%
Unchanged Shares held: Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k, Q2 2022 38.0k
41
BLUEBIRD BIO INC
COM
COM
98,000
$406.0k0.30%
0.30%
Added Shares held: Q3 2021 84.0k, Q4 2021 84.0k, Q1 2022 84.0k, Q2 2022 98.0k
+14.0k
+14,000
16.7%
42
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
33,000
$404.0k0.29%
0.29%
Added Shares held: Q3 2021 0, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 33.0k
+8.0k
+8,000
32.0%
43
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
40,000
$394.0k0.29%
0.29%
Unchanged Shares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
44
SILK RD MED INC
COM
SILK
SILK
10,000
$364.0k0.26%
0.26%
Unchanged Shares held: Q3 2021 0, Q4 2021 8.0k, Q1 2022 10.0k, Q2 2022 10.0k
45
XENCOR INC
COM
XNCR
XNCR
12,300
$337.0k0.25%
0.25%
Unchanged Shares held: Q3 2021 12.3k, Q4 2021 12.3k, Q1 2022 12.3k, Q2 2022 12.3k
46
XENON PHARMACEUTICALS INC
COM
XENE
XENE
10,000
$304.0k0.22%
0.22%
New Shares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 10.0k
47
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
38,000
$301.0k0.22%
0.22%
Unchanged Shares held: Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k, Q2 2022 38.0k
48
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
30,000
$291.0k0.21%
0.21%
Unchanged Shares held: Q3 2021 30.0k, Q4 2021 30.0k, Q1 2022 30.0k, Q2 2022 30.0k
49
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
8,000
$225.0k0.16%
0.16%
Unchanged Shares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k, Q2 2022 8.0k
50
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
20,000
$212.0k0.15%
0.15%
Unchanged Shares held: Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
51
G1 THERAPEUTICS INC
COM
GTHX
GTHX
40,000
$198.0k0.14%
0.14%
Unchanged Shares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
52
STOKE THERAPEUTICS INC
COM
STOK
STOK
15,000
$198.0k0.14%
0.14%
Unchanged Shares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
53
IVERIC BIO INC
COM
OPHT
OPHT
15,000
$144.0k0.10%
0.10%
Unchanged Shares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
54
INFLARX NV
COM
IFRX
IFRX
70,000
$102.0k0.07%
0.07%
Unchanged Shares held: Q3 2021 70.0k, Q4 2021 70.0k, Q1 2022 70.0k, Q2 2022 70.0k
55
CONCERT PHARMACEUTICALS INC
COM
CNCE
CNCE
20,000
$84.0k0.06%
0.06%
Unchanged Shares held: Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
56
ANGION BIOMEDICA CORP
COM
COM
54,392
$62.0k0.05%
0.05%
Unchanged Shares held: Q3 2021 54.4k, Q4 2021 54.4k, Q1 2022 54.4k, Q2 2022 54.4k
57
LAIRD SUPERFOOD INC
COM STK
LSF
LSF
28,000
$53.0k0.04%
0.04%
Unchanged Shares held: Q3 2021 14.0k, Q4 2021 18.0k, Q1 2022 28.0k, Q2 2022 28.0k
58
ASPIRA WOMENS HEALTH INC
COM
COM
83,104
$49.0k0.04%
0.04%
Reduced Shares held: Q3 2021 103.1k, Q4 2021 103.1k, Q1 2022 103.1k, Q2 2022 83.1k
-20.0k
-20,000
-19.4%
59
YIELD10 BIOSCIENCE INC
COM
COM
18,750
$42.0k0.03%
0.03%
Unchanged Shares held: Q3 2021 18.8k, Q4 2021 18.8k, Q1 2022 18.8k, Q2 2022 18.8k
60
SIENTRA INC
COM
SIEN
SIEN
40,000
$34.0k0.02%
0.02%
Unchanged Shares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
61
AKEBIA THERAPEUTICS INC
COM
AKBA
AKBA
0
$00.00%
0.00%
Reduced Shares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 20.0k, Q2 2022 0
-20.0k
-20,000
-100.0%
62
AMARIN CORP PLC
SPONS ADR NEW
SPONS ADR NEW
0
$00.00%
0.00%
Reduced Shares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 0
-300.0k
-300,000
-100.0%
63
BIOGEN INC
COM
BIIB
BIIB
0
$00.00%
0.00%
Reduced Shares held: Q3 2021 12.6k, Q4 2021 12.6k, Q1 2022 10.1k, Q2 2022 0
-10.1k
-10,100
-100.0%
64
VANDA PHARMACEUTICALS INC
COM
VNDA
VNDA
0
$00.00%
0.00%
Reduced Shares held: Q3 2021 80.0k, Q4 2021 60.0k, Q1 2022 50.0k, Q2 2022 0
-50.0k
-50,000
-100.0%